Sara E Matteson-Rusby1, Wilfred R Pigeon, Philip Gehrman, Michael L Perlis. 1. Sleep and Neurophysiology Research Laboratory, Department of Psychiatry, University of Rochester, New York and Behavioral Sleep Medicine, Department of Psychiatry, University of Pennsylvania, Philadelphia.
Abstract
OBJECTIVE: To make the case that insomnia is better conceptualized, not as a symptom, but as a primary disorder. DATA SOURCES: PubMed was searched from 1975-2009 using the search terms insomnia, insomnia and treatment, insomnia and cost, and insomnia and treatment and safety. STUDY SELECTION: English-language articles and other materials were selected to address the following claims: insomnia is unremitting, insomnia is disabling, insomnia is costly, insomnia is pervasive, insomnia is pernicious, and insomnia treatment is safe and effective. DATA EXTRACTION/SYNTHESIS: Insomnia, at least when chronic, should be conceptualized as a comorbid condition, one for which effective interventions are available. CONCLUSIONS: It is speculated that treatment for insomnia will only become the norm when it has been demonstrated that treatment not only addresses the problem of insomnia but also serves to reduce medical and psychiatric morbidity. At that time, the question will no longer be "Why treat insomnia?" but instead "When isn't insomnia treatment indicated?"
OBJECTIVE: To make the case that insomnia is better conceptualized, not as a symptom, but as a primary disorder. DATA SOURCES: PubMed was searched from 1975-2009 using the search terms insomnia, insomnia and treatment, insomnia and cost, and insomnia and treatment and safety. STUDY SELECTION: English-language articles and other materials were selected to address the following claims: insomnia is unremitting, insomnia is disabling, insomnia is costly, insomnia is pervasive, insomnia is pernicious, and insomnia treatment is safe and effective. DATA EXTRACTION/SYNTHESIS: Insomnia, at least when chronic, should be conceptualized as a comorbid condition, one for which effective interventions are available. CONCLUSIONS: It is speculated that treatment for insomnia will only become the norm when it has been demonstrated that treatment not only addresses the problem of insomnia but also serves to reduce medical and psychiatric morbidity. At that time, the question will no longer be "Why treat insomnia?" but instead "When isn't insomnia treatment indicated?"
Authors: A A Nierenberg; B R Keefe; V C Leslie; J E Alpert; J A Pava; J J Worthington; J F Rosenbaum; M Fava Journal: J Clin Psychiatry Date: 1999-04 Impact factor: 4.384
Authors: Joseph A Roscoe; Maralyn E Kaufman; Sara E Matteson-Rusby; Oxana G Palesh; Julie L Ryan; Sadhna Kohli; Michael L Perlis; Gary R Morrow Journal: Oncologist Date: 2007
Authors: Rachel Manber; Jack D Edinger; Jenna L Gress; Melanie G San Pedro-Salcedo; Tracy F Kuo; Tasha Kalista Journal: Sleep Date: 2008-04 Impact factor: 5.849
Authors: Mary Amanda Dew; Carolyn C Hoch; Daniel J Buysse; Timothy H Monk; Amy E Begley; Patricia R Houck; Martica Hall; David J Kupfer; Charles F Reynolds Journal: Psychosom Med Date: 2003 Jan-Feb Impact factor: 4.312
Authors: Traci N Bethea; Eric S Zhou; Eva S Schernhammer; Nelsy Castro-Webb; Yvette C Cozier; Lynn Rosenberg Journal: Sleep Date: 2020-01-13 Impact factor: 5.849
Authors: Joseph A Roscoe; Sheila N Garland; Charles E Heckler; Michael L Perlis; Anita R Peoples; Michelle Shayne; Josée Savard; Nina P Daniels; Gary R Morrow Journal: J Clin Oncol Date: 2014-12-01 Impact factor: 44.544
Authors: Michael L Perlis; Wilfred R Pigeon; Michael A Grandner; Todd M Bishop; Dieter Riemann; Jason G Ellis; Joseph R Teel; Donn A Posner Journal: J Prim Care Community Health Date: 2021 Jan-Dec